MoneyWorks4Me

The company witnessed a 15.38% growth in the revenue at Rs. 945.80 millions for the quarter ended March 2024 as compared to Rs. 819.72 millions during the year-ago period.The company almost doubled its revenue to Rs. 62.19 millions  from Rs. 21.21 millions in the quarter ended March 2024.The company reported a good operating profit of 125.51 millions compared to 87.09 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 945.80 819.72 15.38 3385.40 3030.99 11.69 3385.40 3030.99 11.69
Other Income 22.34 4.39 408.88 33.52 21.92 52.92 33.52 21.92 52.92
PBIDT 125.51 87.09 44.12 357.93 284.92 25.62 357.93 284.92 25.62
Interest 41.18 38.37 7.32 152.35 124.62 22.25 152.35 124.62 22.25
PBDT 84.33 48.72 73.09 205.58 160.30 28.25 205.58 160.30 28.25
Depreciation 17.63 16.63 6.01 84.52 74.81 12.98 84.52 74.81 12.98
PBT 66.70 32.09 107.85 121.06 85.49 41.61 121.06 85.49 41.61
TAX 4.51 10.88 -58.55 18.34 24.23 -24.31 18.34 24.23 -24.31
Deferred Tax 18.76 18.04 3.99 10.78 3.92 175.00 10.78 3.92 175.00
PAT 62.19 21.21 193.21 102.72 61.26 67.68 102.72 61.26 67.68
Equity 158.04 156.90 0.73 158.04 156.90 0.73 158.04 156.90 0.73
PBIDTM(%) 13.27 10.62 24.90 10.57 9.40 12.47 10.57 9.40 12.47
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..